Published in J Virol on December 01, 1990
A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J Virol (1991) 2.30
A domain at the 3' end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J Virol (1991) 2.14
Identification and characterization of a coronavirus packaging signal. J Virol (1992) 2.01
Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells. J Virol (2000) 1.89
Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J Virol (1994) 1.85
Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J Virol (1993) 1.71
Homologous RNA recombination allows efficient introduction of site-specific mutations into the genome of coronavirus MHV-A59 via synthetic co-replicating RNAs. Nucleic Acids Res (1992) 1.64
Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging. J Virol (2001) 1.56
The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations. J Virol (1992) 1.49
Mutagenic analysis of the coronavirus intergenic consensus sequence. J Virol (1992) 1.45
Effect of intergenic consensus sequence flanking sequences on coronavirus transcription. J Virol (1993) 1.44
Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA. J Virol (2001) 1.41
Host protein interactions with the 3' end of bovine coronavirus RNA and the requirement of the poly(A) tail for coronavirus defective genome replication. J Virol (2000) 1.40
Coding capacity determines in vivo accumulation of a defective RNA of clover yellow mosaic virus. J Virol (1992) 1.31
Replication and packaging of transmissible gastroenteritis coronavirus-derived synthetic minigenomes. J Virol (1999) 1.31
Mouse hepatitis virus S RNA sequence reveals that nonstructural proteins ns4 and ns5a are not essential for murine coronavirus replication. J Virol (1991) 1.25
Translation but not the encoded sequence is essential for the efficient propagation of the defective interfering RNAs of the coronavirus mouse hepatitis virus. J Virol (1995) 1.25
Evidence for coronavirus discontinuous transcription. J Virol (1994) 1.20
The 3' untranslated region of coronavirus RNA is required for subgenomic mRNA transcription from a defective interfering RNA. J Virol (1996) 1.14
Murine coronavirus packaging signal confers packaging to nonviral RNA. J Virol (1997) 1.13
cis-acting sequences required for coronavirus infectious bronchitis virus defective-RNA replication and packaging. J Virol (2001) 1.12
Replication and packaging of coronavirus infectious bronchitis virus defective RNAs lacking a long open reading frame. J Virol (1996) 1.09
Identification of a bovine coronavirus packaging signal. J Virol (2000) 1.09
In vivo accumulation of a turnip crinkle virus defective interfering RNA is affected by alterations in size and sequence. J Virol (1991) 1.06
RNA recombination in a coronavirus: recombination between viral genomic RNA and transfected RNA fragments. J Virol (1992) 1.03
Coronavirus transcription early in infection. J Virol (1998) 0.95
Two murine coronavirus genes suffice for viral RNA synthesis. J Virol (1995) 0.93
Replication of murine coronavirus defective interfering RNA from negative-strand transcripts. J Virol (1996) 0.87
The structure and functions of coronavirus genomic 3' and 5' ends. Virus Res (2015) 0.87
Effect of template size on accumulation of defective interfering RNAs in protoplasts. J Virol (1994) 0.86
Functional analysis of the murine coronavirus genomic RNA packaging signal. J Virol (2013) 0.86
New structure model for the packaging signal in the genome of group IIa coronaviruses. J Virol (2007) 0.85
C-E1 fusion protein synthesized by rubella virus DI RNAs maintained during serial passage. Virology (2006) 0.78
Recognition of the murine coronavirus genomic RNA packaging signal depends on the second RNA-binding domain of the nucleocapsid protein. J Virol (2014) 0.78
A key role for the carboxy-terminal tail of the murine coronavirus nucleocapsid protein in coordination of genome packaging. Virology (2016) 0.75
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1991) 0.75
RNA-binding domain in the nucleocapsid protein of gill-associated nidovirus of penaeid shrimp. PLoS One (2011) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A simple and very efficient method for generating cDNA libraries. Gene (1983) 55.36
Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci U S A (1977) 41.76
3'-terminal nucleotide sequence of encephalomyocarditis virus RNA determined by reverse transcriptase and chain-terminating inhibitors. Proc Natl Acad Sci U S A (1978) 6.67
RNA of mouse hepatitis virus. J Virol (1978) 4.27
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid. J Virol (1980) 3.82
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
The virus-specific intracellular RNA species of two murine coronaviruses: MHV-a59 and MHV-JHM. Virology (1981) 3.57
Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch Gesamte Virusforsch (1974) 3.24
Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06
Defective interfering particles of poliovirus. II. Nature of the defect. J Mol Biol (1973) 2.89
Construction and characterization of poliovirus subgenomic replicons. J Virol (1988) 2.69
Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59. Virology (1989) 2.69
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology (1984) 2.13
Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J Virol (1985) 2.10
In vitro construction of poliovirus defective interfering particles. J Virol (1989) 2.10
Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07
High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95
Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89
Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology (1988) 1.87
Cyclic production of vesicular stomatitis virus caused by defective interfering particles. J Infect Dis (1974) 1.84
Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein. J Virol (1989) 1.82
Defective interfering particles of mouse hepatitis virus. Virology (1984) 1.76
Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs. Virology (1988) 1.73
Translation and processing of mouse hepatitis virus virion RNA in a cell-free system. J Virol (1986) 1.51
Biosynthesis, structure, and biological activities of envelope protein gp65 of murine coronavirus. Virology (1989) 1.19
Coronavirus: a jumping RNA transcription. Cold Spring Harb Symp Quant Biol (1987) 1.15
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science (1999) 6.21
Molecular cloning and sequencing of a human hepatitis delta (delta) virus RNA. Nature (1987) 4.52
Adenylic acid-rich sequence in RNAs of Rous sarcoma virus and Rauscher mouse leukaemia virus. Nature (1972) 4.49
RNA of mouse hepatitis virus. J Virol (1978) 4.27
The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology (1991) 4.07
Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell (1994) 4.06
Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J Virol (1981) 4.00
Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc Natl Acad Sci U S A (1984) 3.81
Human hepatitis delta virus RNA subfragments contain an autocleavage activity. Proc Natl Acad Sci U S A (1989) 3.51
Avian tumor virus RNA: a comparison of three sarcoma viruses and their transformation-defective derivatives by oligonucleotide fingerprinting and DNA-RNA hybridization. Proc Natl Acad Sci U S A (1973) 3.46
Ribonucleic acid components of murine sarcoma and leukemia viruses. Proc Natl Acad Sci U S A (1973) 3.42
Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J Virol (1988) 3.11
Presence of leader sequences in the mRNA of mouse hepatitis virus. J Virol (1983) 3.06
Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II. Cell (1995) 3.01
High-frequency RNA recombination of murine coronaviruses. J Virol (1986) 2.91
Replication of mouse hepatitis virus: negative-stranded RNA and replicative form RNA are of genome length. J Virol (1982) 2.86
Specification of kinetochore-forming chromatin by the histone H3 variant CENP-A. J Cell Sci (2001) 2.82
Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J Virol (1983) 2.80
Drosophila TAFII150: similarity to yeast gene TSM-1 and specific binding to core promoter DNA. Science (1994) 2.48
Characterization of two RNA polymerase activities induced by mouse hepatitis virus. J Virol (1982) 2.46
The 3'-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site. J Virol (1998) 2.36
Further characterization of mRNA's of mouse hepatitis virus: presence of common 5'-end nucleotides. J Virol (1982) 2.34
Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology (1999) 2.33
Comparative analysis of RNA genomes of mouse hepatitis viruses. J Virol (1981) 2.30
Restriction enzyme sites on the avian RNA tumor virus genome. J Virol (1978) 2.29
Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol (1998) 2.28
Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome. J Virol (1997) 2.28
Occurrence of partial deletion and substitution of the src gene in the RNA genome of avian sarcoma virus. Proc Natl Acad Sci U S A (1977) 2.22
Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol (1985) 2.21
The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription. Virology (1987) 2.17
Characterization of hepatitis delta antigen: specific binding to hepatitis delta virus RNA. J Virol (1990) 2.17
Leader sequences of murine coronavirus mRNAs can be freely reassorted: evidence for the role of free leader RNA in transcription. Proc Natl Acad Sci U S A (1986) 2.16
A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J Virol (1999) 2.16
Antigenic relationships of murine coronaviruses: analysis using monoclonal antibodies to JHM (MHV-4) virus. Virology (1983) 2.11
Phosphoproteins of murine hepatitis viruses. J Virol (1979) 2.07
Characterization of leader-related small RNAs in coronavirus-infected cells: further evidence for leader-primed mechanism of transcription. Virus Res (1985) 2.07
High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J Virol (1989) 1.95
An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence. Virology (1999) 1.90
Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase. J Virol (1987) 1.89
Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology (1988) 1.87
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Identification of a domain required for autoproteolytic cleavage of murine coronavirus gene A polyprotein. J Virol (1989) 1.82
Identification of a new transcriptional initiation site and the corresponding functional gene 2b in the murine coronavirus RNA genome. J Virol (1989) 1.77
Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J Virol (1988) 1.76
Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J Virol (1992) 1.75
Identification of the catalytic sites of a papain-like cysteine proteinase of murine coronavirus. J Virol (1993) 1.74
Differential subcellular localization of hepatitis C virus core gene products. Virology (1995) 1.73
A human condensin complex containing hCAP-C-hCAP-E and CNAP1, a homolog of Xenopus XCAP-D2, colocalizes with phosphorylated histone H3 during the early stage of mitotic chromosome condensation. Mol Cell Biol (2000) 1.73
Defective-interfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs. Virology (1988) 1.73
Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J Virol (1993) 1.71
Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc Natl Acad Sci U S A (1997) 1.70
An in vitro system for the leader-primed transcription of coronavirus mRNAs. EMBO J (1990) 1.69
Genome of avian myelocytomatosis virus MC29: analysis by heteroduplex mapping. Proc Natl Acad Sci U S A (1979) 1.68
Identification of two distinct human SMC protein complexes involved in mitotic chromosome dynamics. Proc Natl Acad Sci U S A (1998) 1.68
Phosphoproteins of Rous sarcoma viruses. Virology (1976) 1.67
Colocalization and membrane association of murine hepatitis virus gene 1 products and De novo-synthesized viral RNA in infected cells. J Virol (1999) 1.67
Differences between the envelope glycoproteins and glycopeptides of avian tumor viruses released from transformed and from nontransformed cells. Virology (1972) 1.67
Further characterization of mouse hepatitis virus RNA-dependent RNA polymerases. Virology (1984) 1.64
Three different cellular proteins bind to complementary sites on the 5'-end-positive and 3'-end-negative strands of mouse hepatitis virus RNA. J Virol (1993) 1.64
Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implications for the role of minus-strand RNA in RNA replication and transcription. J Virol (1994) 1.64
Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol (1992) 1.63
Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J Gen Virol (1982) 1.62
Heterogeneity of gene expression of the hemagglutinin-esterase (HE) protein of murine coronaviruses. Virology (1991) 1.60
Reversible cleavage and ligation of hepatitis delta virus RNA. Science (1989) 1.59
Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. J Virol (1994) 1.58
Random nature of coronavirus RNA recombination in the absence of selection pressure. Virology (1991) 1.57
RNA-binding activity of hepatitis delta antigen involves two arginine-rich motifs and is required for hepatitis delta virus RNA replication. J Virol (1993) 1.57
Sequence conservation and divergence of hepatitis delta virus RNA. Virology (1990) 1.56
Analysis of intracellular small RNAs of mouse hepatitis virus: evidence for discontinuous transcription. Virology (1987) 1.52
Transcription of hepatitis delta antigen mRNA continues throughout hepatitis delta virus (HDV) replication: a new model of HDV RNA transcription and replication. J Virol (1998) 1.51
Homotypic interaction and multimerization of hepatitis C virus core protein. Virology (1996) 1.51
Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template. J Biol Chem (2000) 1.46
Sequence and structure of the catalytic RNA of hepatitis delta virus genomic RNA. J Mol Biol (1992) 1.44
17-year follow-up of a randomized prospective controlled trial of adjuvant intravesical doxorubicin in the treatment of superficial bladder cancer. Int Braz J Urol (2005) 1.44
Evolution of the 5'-end of genomic RNA of murine coronaviruses during passages in vitro. Virology (1989) 1.43
Interaction of RAFT1 with gephyrin required for rapamycin-sensitive signaling. Science (1999) 1.42
Immunophilins in the nervous system. Neuron (1998) 1.42
Requirement of the 5'-end genomic sequence as an upstream cis-acting element for coronavirus subgenomic mRNA transcription. J Virol (1994) 1.41
Heterogeneous nuclear ribonucleoprotein a1 binds to the 3'-untranslated region and mediates potential 5'-3'-end cross talks of mouse hepatitis virus RNA. J Virol (2001) 1.41
Heterogeneous nuclear ribonucleoprotein A1 regulates RNA synthesis of a cytoplasmic virus. EMBO J (2000) 1.38
Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton. Proc Natl Acad Sci U S A (1998) 1.38
Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression. J Neurovirol (1995) 1.37
RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases. Mol Cell Biol (2000) 1.36
A pregnancy-specific glycoprotein is expressed in the brain and serves as a receptor for mouse hepatitis virus. Proc Natl Acad Sci U S A (1995) 1.34
Replication of hepatitis delta virus RNA: effect of mutations of the autocatalytic cleavage sites. J Virol (1993) 1.34
Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization. Virology (1997) 1.33
In vivo RNA-RNA recombination of coronavirus in mouse brain. J Virol (1988) 1.33
Multiple recombination sites at the 5'-end of murine coronavirus RNA. Virology (1987) 1.32
Oligomerization of hepatitis delta antigen is required for both the trans-activating and trans-dominant inhibitory activities of the delta antigen. J Virol (1992) 1.32
Chromosome 1 contains the endogenous RAV-0 retrovirus sequences in chicken cells. Proc Natl Acad Sci U S A (1979) 1.32
Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K. J Biol Chem (1998) 1.32
RNA conformational requirements of self-cleavage of hepatitis delta virus RNA. Mol Cell Biol (1990) 1.30
Avian erythroblastosis virus: transformation-specific sequences form a contiguous segment of 3.25 kb located in the middle of the 6-kb genome. Virology (1979) 1.29
In vitro synthesis and characterisation of full- and half-genome length complementary DNA from avian oncoviruses. Nature (1978) 1.29
Polypyrimidine tract-binding protein binds to the leader RNA of mouse hepatitis virus and serves as a regulator of viral transcription. J Virol (1999) 1.28